HOYA Corporation (TYO:7741)
17,710
-490 (-2.69%)
Feb 21, 2025, 3:30 PM JST
HOYA Corporation Revenue
HOYA Corporation had revenue of 220.85B JPY in the quarter ending December 31, 2024, with 12.59% growth. This brings the company's revenue in the last twelve months to 837.44B, up 10.36% year-over-year. In the fiscal year ending March 31, 2024, HOYA Corporation had annual revenue of 762.61B with 5.39% growth.
Revenue (ttm)
837.44B
Revenue Growth
+10.36%
P/S Ratio
7.38
Revenue / Employee
23.46M
Employees
35,702
Market Cap
6,118.47B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 762.61B | 39.03B | 5.39% |
Mar 31, 2023 | 723.58B | 62.12B | 9.39% |
Mar 31, 2022 | 661.47B | 113.55B | 20.72% |
Mar 31, 2021 | 547.92B | -28.63B | -4.96% |
Mar 31, 2020 | 576.55B | 10.74B | 1.90% |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Chugai Pharmaceutical | 1,170.61B |
Takeda Pharmaceutical Company | 4,579.02B |
Daiichi Sankyo Company | 1,795.99B |
Terumo | 1,011.15B |
Otsuka Holdings | 2,329.86B |
Astellas Pharma | 1,867.63B |
Olympus | 993.33B |
Shionogi & | 456.87B |